Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02878837Phase 4Completed
Phase 4, randomised, open-label trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by IAMSPE. Primary endpoints: Depth of Sedation, Respiratory depression and 2 more. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02878837.